Change in the Management of Neurotune AG

28-Jan-2009 - Switzerland

Neurotune AG announced a change in the management. Starting March 1st 2009, Dr. Bruno Oesch will take over the position of Chief Executive Officer from Dr. Andreas J. Schulze, who joined Neurotune in 2005 and is holding the position of CEO since 2006. Andreas J. Schulze will leave at his request to take on a fresh challenge in another company shortly.

Bruno Oesch is co-founder of Prionics AG and Neurotune AG. Serving as Chairman of the Board of Directors since Neurotune's foundation in 2005 he has been significantly involved in the strategic alignment of the company.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...